Arbutus Biopharma
ABUS
#6238
Rank
ยฃ0.52 B
Marketcap
ยฃ2.75
Share price
0.58%
Change (1 day)
88.81%
Change (1 year)

Revenue for Arbutus Biopharma (ABUS)

Revenue in 2024 (TTM): ยฃ8.08 Million

According to Arbutus Biopharma 's latest financial reports the company's current revenue (TTM ) is ยฃ8 Million. In 2023 the company made a revenue of ยฃ14.23 Million a decrease over the revenue in the year 2022 that were of ยฃ32.25 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arbutus Biopharma from 2008 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ8.08 M-43.25%
2023 ยฃ14.23 M-55.85%
2022 ยฃ32.25 M296.21%
2021 ยฃ8.14 M60.48%
2020 ยฃ5.07 M10.65%
2019 ยฃ4.58 M-2.12%
2018 ยฃ4.68 M-40.84%
2017 ยฃ7.91 M555.19%
2016 ยฃ1.2 M-92.8%
2015 ยฃ16.78 M74.76%
2014 ยฃ9.6 M2.36%
2013 ยฃ9.38 M8.23%
2012 ยฃ8.66 M-20.22%
2011 ยฃ10.86 M-21.36%
2010 ยฃ13.81 M70.89%
2009 ยฃ8.08 M21.1%
2008 ยฃ6.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.11 B 1,353.93%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas